ScoreWhy is Guiyang Xintian Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -3.20% and Operating profit at -27.45% over the last 5 years
2
The company has declared Negative results for the last 14 consecutive quarters
- NET PROFIT(9M) At CNY 6.84 MM has Grown at -73.84%
- INTEREST(HY) At CNY 9.73 MM has Grown at 113.67%
3
With ROE of 0.67%, it has a very expensive valuation with a 1.44 Price to Book Value
- Over the past year, while the stock has generated a return of -19.55%, its profits have fallen by -79.4%
- At the current price, the company has a high dividend yield of 0.4
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -19.55% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Guiyang Xintian Pharmaceutical Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Guiyang Xintian Pharmaceutical Co., Ltd.
-23.19%
-0.27
43.82%
China Shanghai Composite
0.9%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-3.20%
EBIT Growth (5y)
-27.45%
EBIT to Interest (avg)
5.78
Debt to EBITDA (avg)
4.64
Net Debt to Equity (avg)
0.37
Sales to Capital Employed (avg)
0.47
Tax Ratio
20.15%
Dividend Payout Ratio
77.52%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.49%
ROE (avg)
8.54%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
210
Industry P/E
Price to Book Value
1.41
EV to EBIT
96.54
EV to EBITDA
39.87
EV to Capital Employed
1.30
EV to Sales
3.04
PEG Ratio
NA
Dividend Yield
0.39%
ROCE (Latest)
1.35%
ROE (Latest)
0.67%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 126.59 MM
RAW MATERIAL COST(Y)
Fallen by -3.34% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 31.93 %
DEBTORS TURNOVER RATIO(HY)
Highest at 2.7 times
PRE-TAX PROFIT(Q)
At CNY 2.99 MM has Grown at 65.43%
-7What is not working for the Company
INTEREST(9M)
At CNY 14.08 MM has Grown at 64.31%
ROCE(HY)
Lowest at 0.67%
NET SALES(Q)
Lowest at CNY 153.22 MM
Here's what is working for Guiyang Xintian Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 126.59 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Pre-Tax Profit
At CNY 2.99 MM has Grown at 65.43%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Debt-Equity Ratio
Lowest at 31.93 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 2.7 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -3.34% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Guiyang Xintian Pharmaceutical Co., Ltd.
Interest
At CNY 14.08 MM has Grown at 64.31%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
Lowest at CNY 153.22 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Footer loading
